PHILADELPHIA, April 06, 2017 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ:ONCE) announced updated preliminary data today from 10 infused participants in the ongoing Phase 1/2 clinical trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results